The primary endpoint, a reduction in DGF from 26.5 to 20.8%, was only borderline significant ( p = 0.05) when one-sided statistical tests were used in the analysis.
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
Seeking professional help to reach climbing goals was borderline significant ( p = 0.05).
Race interaction: borderline significant (overall p = 0.05).
After accounting for competing mortality, there were borderline significant differences observed across the group of PGS _ FNBMD ldpred for MOF (p = 0.05), but not for HF (p = 0.71).
Interaction analyses between dicarbonyls and sex for fibrosis category revealed a borderline significant interaction for MGO × sex ( p = 0.05, OR = 0.51, 95% CI: 0.25–1.00), a significant interaction for GO × sex ( p = 0.002, OR = 0.42, 95% CI: 0.24–0.72), and no significant interaction for 3‐DG × sex ( p = 0.46, OR = 0.80, 95% CI: 0.45–1.44).
On the contrary, HbA 1c slightly increased in youth with type 1 diabetes in one study [ 25 ], both in the coping skills training group and in the control one (with no difference between the two), but this variation was only borderline significant ( P =.05).
BMI showed a borderline significant correlation with C4 (ρ = 0.343, p = 0.050).
There was a significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 3.8% (P = 0.02) onBV5A‐PR and a borderline significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 6.4% (P = 0.05) onBV5A‐PRA.
Similar observations were demonstrated in the CON group, with a borderline significant ( p = 0.05) reduction in SBP of −1.4 mmHg [−2.8;0.0] and a significant ( p = 0.03) reduction in DBP of −1.5 mmHg [−2.8;−0.1], resulting in a reduction ( p = 0.01) in MAP of −1.5 mmHg [−2.6;−0.3].
Age showed a borderline significant link with mortality (p=0.05), suggesting a slight risk increase with age.
There was a borderline significant difference between pre‐presentation and comparison intention to complete the test ( p = 0.05), with 66% intending to do so in the intervention group and 79% in the comparison group.
Sensitivity analysis of the association of LI with cirrhosis showed a borderline significant difference in risk of cirrhosis for LI1 versus LI2–3 (HR [95% CI]: 0.44 [0.20–1.00], p = 0.050).
A borderline significant association remained after controlling for differences in age category, sex, and site location (odds ratio [OR]: 1.70, 95% CI [1.00, 2.88], p = 0.05).
The effect of loneliness on physical activity was borderline significant in the actively isolated group ( p = 0.050).
ADAE prediction generalizability Overall, there was no significant association between the ADAE prediction performance and the patient age ( p = 0.104), skin type ( p = 0.587; excluding unknown skin types, and skin types V + VI due to low sample size (<25)), or lesion location domain ( p = 0.233; excluding lesions in unknown locations, and oral/genital lesions due to low sample size (<25)), the technical domain (i.e., camera setup; p = 0.068) or the dermatologists’ diagnostic confidence score, although borderline significant ( p = 0.050).
Morning basal cortisol levels did not differ significantly among the groups ( P = 0.15), but the case group had slightly higher levels compared to control group 2, with the difference being borderline significant ( P = 0.05).
Supervised combined exercise programs showed a borderline significant reduction in BMI (SMD −1.25; 95% CI: −2.50 to 0.01; p = 0.05; I 2 = 59%), based on 3 studies with 23 patients.
Hematoma volume showed a borderline significant association (Exp(B) = 1.006, p = 0.050), suggesting that larger hematoma volumes slightly increased the likelihood of osteoclastic intervention.
PBM vs Control: PBM showed a borderline significant improvement compared to Control (-0.52 mm, p=0.050) with a small to moderate effect size.
Similar findings were obtained for those using non-aspirin NSAIDs, although the results were only borderline significant (p = 0.050).
Age was a borderline significant predictor ( p = 0.05).
Overall, the magnitude of mean change in CD4 + T cell-associated HIV-1 DNA was similar between baseline and all treatment time points with a borderline significant mean change in HIV-1 DNA levels from baseline to treatment week 4 being observed in the primary efficacy population (mean −0.21 log 10 copies/10 6 cells; p = 0.05) but not from baseline to week 12 (mean: −0.17 log 10 copies/10 6 cells; p = 0.13) as shown in Table S3 .
Individuals randomized to receive azathioprine did not see a reduction in the need for lid surgery (OR = 0.60; 95% CI .12, 3.04; P = .54); however, a borderline significant result was observed for radiotherapy (OR = 0.17; 95% CI .03, 1.03; P = .05) with the 95% CI crossing equality (Supplementary Table 3) ( 27 ).
Home O 2 use was borderline significant after adjustment for these additional variables (OR: 1.74; 95% CI: 0.99 - 3.04, P = 0.050.) Figure 1 demonstrates a Kaplan-Meir survival analysis showing a significant increase in all cause mortality in the home O 2 cohort with an overall mean (95% CI) survival time of 6.2 (5.9 - 6.5) years (P < 0.001).
Despite the limited number of animals that could be tested in these experimental settings, this finding was borderline significant (Fisher exact test; p = 0.05).